These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9114037)

  • 1. Self and viral peptides can initiate lysis by autologous natural killer cells.
    Mandelboim O; Wilson SB; Valés-Gómez M; Reyburn HT; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4604-9. PubMed ID: 9114037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
    Mandelboim O; Reyburn HT; Valés-Gómez M; Pazmany L; Colonna M; Borsellino G; Strominger JL
    J Exp Med; 1996 Sep; 184(3):913-22. PubMed ID: 9064351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.
    Zappacosta F; Borrego F; Brooks AG; Parker KC; Coligan JE
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6313-8. PubMed ID: 9177214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.
    Colonna M; Borsellino G; Falco M; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12000-4. PubMed ID: 8265660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
    Biassoni R; Falco M; Cambiaggi A; Costa P; Verdiani S; Pende D; Conte R; Di Donato C; Parham P; Moretta L
    J Exp Med; 1995 Aug; 182(2):605-9. PubMed ID: 7629517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.
    Davis DM; Mandelboim O; Luque I; Baba E; Boyson J; Strominger JL
    J Exp Med; 1999 Apr; 189(8):1265-74. PubMed ID: 10209043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cell receptor-mediated recognition of HLA-E.
    García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
    Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
    Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
    Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.
    Peruzzi M; Wagtmann N; Long EO
    J Exp Med; 1996 Oct; 184(4):1585-90. PubMed ID: 8879234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
    Rajagopalan S; Long EO
    J Exp Med; 1997 Apr; 185(8):1523-8. PubMed ID: 9126935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
    J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
    Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
    Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
    J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
    Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
    Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.